Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction

Journal of Cellular Physiology

Volumn 201, Issue 1, 2004, Pages 17-25

  Kanatani, Masanori ^a   Sugimoto, Toshitsugu ^a   Sowa, Hideaki ^a   Kobayashi, Tatsuya ^a   Kanzawa, Michiko ^a   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 6; LIOTHYRONINE; LIOTHYRONINE RECEPTOR; LIOTHYRONINE RECEPTOR ALPHA 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; PROTEIN; PROTEIN C FOS; RANK PROTEIN; THYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLAST CELL; BONE CELL; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; GENE; GENE EXPRESSION; HEMATOPOIETIC BLAST CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; ONCOGENE C FOS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPROTEGERIN GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN INTERACTION; RANKL GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; STEM CELL; STROMA CELL; UPREGULATION;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OSTEOCLASTS; OSTEOPROTEGERIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-FOS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, THYROID HORMONE; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SPLEEN; TRIIODOTHYRONINE;

EID: 4444358792     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20041     Document Type: Article

References (54)

1. Al-Humidan A, Ralston SH, Hughes DE, Chapman K, Aarden L, Russell RGG, Gowen M. 1991. Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. J Bone Miner Res 6:3-8.
2. Allain TJ, McGregor AM. 1993. Thyroid hormones and bone. J Endocrinol 139:9-18.
3. Allain TJ, Chambers TJ, Flanagan AM, McGregor AM. 1992. Triiodothyronine stimulates rat osteoclastic bone resorption by an indirect effect. J Endocrinol 133:327-331.
4. Allain TJ, Yen PM, Flanagan AM, McGregor AM. 1996. The isoform-specific expression of the tri-iodothyronine receptor in osteoblasts and osteoclasts. Eur J Clin Invest 26:418-425.
5. Azuma Y, Kaji K, Katagiri R, Takeshita S, Kudo A. 2000. Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts. J Biol Chem 275:4858-4864.
6. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. 1994. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrnol Metab 78:423-427.
7. Britto JM, Fenton AJ, Holloway WR, Nicholson GC. 1994. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 134:169-176.
8. Chambers TJ. 2000. Regulation of the differentiation and function of osteoclasts. J Pathol 192:4-13.
9. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
10. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM. 1995. Risk factors for hip fracture in white women. N Engl J Med 332:767-773.
11. Diamond T, Nery L, Hales I. 1991. A therapeutic dilemma: Suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 72:1184-1188.
12. Fujimori A, Tsutsumi M, Fukase M, Fujita T. 1989. Cyclooxygenase inhibitors enhance cell growth in an osteoblastic cell line, MC3T3-E1. J Bone Miner Res 5:697-704.
13. Garnero P, Vassay V, Bertholin A, Riou JP, Delmas PD. 1994. Markers of bone turnover in hyperthyroidism and the effects of treatment. J Clin Endocrinol Metab 78:955-959.
14. Gauldie J, Richards C, Harbish D, Lansdorp P, Baumann H. 1987. Interferon beta2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251-7255.
15. Girasole G, Jilka RL, Passeri G. 1992. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891.
16. Hakeda Y, Hiura K, Sato T, Okazaki R, Matsumoto T, Ogata E, Ishitani R, Kumegawa M. 1989. Existence of parathyroid hormone binding sites on murine hemopoietic blast cells. Biochem Biophys Res Commun 163:1481-1486.
17. Harvey RD, McHardy KC, Reid IW, Paterson F, Bewsher PD, Duncan A, Robins SP. 1991. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J Clin Endocrinol Metab 72:1189-1194.
18. Hoffmann O, Klaushofer K, Koller K, Peterlik M, Mavreas T, Stern P. 1986. Indomethacin inhibits thrombin-, but not thyroxine-stimulated resorption of fetal rat limb bones. Prostaglandins 31: 601-608.
19. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T. 1990. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303.
20. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC. 1992. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257:88-91.
21. Jimi E, Nakamura I, Duong LT, Ikebe T, Takahashi N, Rodan GA, Suda T. 1999. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 247:84-93.
22. Kakudo S, Miyazawa K, Kameda T, Mano H, Mori Y, Yuasa T, Nakamaru Y, Shiokawa M, Nagahira K, Tokunaga S, Hakeda Y, Kumegawa M. 1996. Isolation of highly enriched rabbit osteoclasts from collagen gels: A new assay system for bone-resorbing activity of mature osteoclasts. J Bone Miner Metab 14:129-136.
23. Kanatani M, Sugimoto T, Fukase M, Chihara K. 1994. Role of interleukin-6 and prostaglandins in the effect of monocyte-conditioned medium on osteoclast formation. Am J Physiol 267 (Endocrinol Metab 30):E868-E876.
24. Kanatani M, Sugimoto T, Takahashi Y, Kaji H, Kitazawa R, Chihara K. 1998. Estrogen via the estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast formation. J Bone Miner Res 13:854-862.
25. Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K. 2003. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity. J Cell Physiol 196:180-189.
26. Kasono K, Sato K, Han DC, Fujii Y, Tsushima T, Shizume K. 1988. Stimulation of alkaline phosphatase activity by thyroid hormone in mouse osteoblast-like cells (MC3T3-E1): A possible mechanism of hyperalkaline phosphatasia in hyperthyroidism. Bone Miner 4:355-363.
27. Kassem M, Mosekilde L, Eriksen EF. 1993. Effects of triiodothyronine on DNA synthesis and differentiation markers of normal human osteoblast-like cells in vitro. Biochem Mol Biol Int 30: 779-788.
28. Klaushofer K, Hoffmann O, Gleispach H, Leis H-J, Czerwenka E, Koller K, Peterlik M. 1989. Bone-resorbing activity of thyroid hormones is related to prostaglandin production in cultured neonatal mouse calvaria. J Bone Miner Res 4:305-312.
29. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T. 2000. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-286.
30. Kurihara N, Suda T, Miura Y, Nakauchi H, Kodama H, Hiura K, Hakeda Y, Kumegawa M. 1989. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 74:1295-1302.
31. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
32. Lakatos P, Foldes J, Horvath C, Kiss L, Tatrai A, Takacs I, Tarjan G, Stern PH. 1997. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab 82:78-81.
33. LeBron BA, Pekary AE, Mirell C, Hahn TJ, Hershman JM. 1989. Thyroid hormone 5′-deiodinase activity, nuclear binding, and effects on mitogenesis in UMR-106 osteoblastic osteosarcoma cells. J Bone Miner Res 4:173-178.
34. Lee MS, Kim SY, Lee MC, Cho BY, Lee HK, Koh CS, Min HK. 1990. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab 70:766-770.
35. Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, Suda T, Takahashi N. 2002. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143:3105-3113.
36. Mano H, Yuasa T, Kameda T, Miyazawa K, Nakamaru Y, Shiokawa M, Mori Y, Yamada T, Miyata K, Shindo H, Azuma H, Hakeda Y, Kumegawa M. 1996. Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun 223:637-642.
37. Masuda M, Yasuhara S, Yamashita M, Shibuya M, Odaka T. 1990. Nucleotide sequence of the murine thyroid hormone receptor (alpha-1) cDNA. Nucleic Acids Res 18:3055.
38. Matsuo K, Owens JM, Tonko M, Elliot C, Chambers TJ, Wagner EF. 2000. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nature Genetics 24:184-187.
39. 3 in osteoclast formation. Biochem Biophys Res Commun 291:987-994.
40. Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG. 1976. Direct stimulation of bone resorption by thyroid hormones. J Clin Invest 58:529-534.
41. Ohsaki Y, Takahashi S, Scarcez T, Demulder A, Nishihara T, Williams R, Roodman GD. 1992. Evidence for an autocrine/paracrine role for IL-6 in bone resorption by giant cell tumors of bone. Endocrinology 131:2229-2234.
42. Owens JM, Matsuo K, Nicholson GC, Wagner EF, Chambers TJ. 1999. Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines. J Cell Physiol 179:170-178.
43. Rizzoli R, Poser J, Burgi U. 1986. Nuclear thyroid hormone receptors in cultured bone cells. Metabolism 35:71-74.
44. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliot R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
45. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357.
46. Suda K, Woo JT, Takami M, Sexton PM, Nagai K. 2002. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-a, IL-1, and RANKL. J Cell Physiol 190: 101-108.
47. Sugimoto T, Kanatani M, Kaji H, Yamaguchi T, Fukase M, Chihara K. 1993a. Second messenger signaling of PTH- and PTHRP-stimulated osteoclast-like cell formation from hemopoietic blast cells. Am J Physiol 265 (Endocrinol Metab 28):E367-E373.
48. Sugimoto T, Kanatani M, Kano J, Kaji H, Tsukamoto T, Yamaguchi T, Fukase M, Chihara K. 1993b. Effects of high calcium concentration on the functions and interactions of osteoblastic cells and monocytes and on the formation of osteoclast-like cells. J Bone Miner Res 8:1445-1452.
49. Takada Y, Kusuda M, Hiura K, Sato T, Mochizuki H, Nagao Y, Tomura M, Yahiro M, Hakeda Y, Kawashima H, Kumegawa M. 1992. A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells. Bone Miner 17:347-359.
50. Takahashi N, Udagawa N, Suda T. 1999. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun 256:449-455.
51. Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T. 2002. Rankl maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416:744-749.
52. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
53. Toh SH, Claunch BC, Brown PH. 1985. Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 145:883-886.
54. Weetmann AP, Bright-Thomas R, Freeman M. 1990. Regulation of interleukin-6 release by human thyrocytes. J Endocrinol 127:357-361.